Hedge Funds May Rebound and Spoil Buffett’s Bet (WSJ) Timing isn’t everything, but it sure helps. Six years ago, Warren Buffett, chairman......
(read more)
December 9 - Hedge Funds - Comments
While John Paulson’s name is synonymous with outsized bets on mortgage-backed securities and gold, he also runs a fairly large equity portfolio at Paulson......
(read more)
November 15 - Hedge Funds, News - Comments
We have gone through Citadel’s most recent 13F compared to the previous one (see a history of Citadel’s stock picks) and here’s what we noticed......
(read more)
November 15 - Hedge Funds, News - Comments
Clint Carlson of Carlson Capital has also shared his big bets from this fall. In a recent SEC filing, Carlson revealed his biggest bet is Bunge Ltd (NYSE......
(read more)
November 14 - Hedge Funds, News - Comments
Citadel, Tiger Cubs Turn to Retail Stocks (InstitutionalInvestorsAlpha) A growing number of managers of very large, well-known hedge fund firms have been......
(read more)
November 8 - Hedge Funds, News - Comments
Steven Cohen insider trading: It’s no secret that Steven Cohen and SAC Capital are going through a rough patch, mainly because of the insider trading......
(read more)
October 9 - Hedge Funds, News - Comments
The Chinese calendar says 2013 is the year of the snake, but the market says it’s the year of biotech. Major biotechnology ETFs and indices have......
(read more)
September 17 - News - Comments
Trading of biopharmaceutical company Theravance Inc (NASDAQ:THRX) was halted on Tuesday. A major decision hung in the balance as the U.S. Food and Drug......
(read more)
September 11 - News - Comments
With second-quarter earnings season now in the books and about a month to go before third-quarter earnings kicks off, biotech savvy investors are in for......
(read more)
September 9 - News - Comments
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long......
(read more)
September 4 - News - Comments
What’s a smart Alkermes Plc (NASDAQ:ALKS) investor to do? In the financial world, there are plenty of indicators shareholders can use to watch......
(read more)
September 3 - News - Comments
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......
(read more)
August 30 - Hedge Funds, News - Comments
Shares of Perrigo Company (NYSE:PRGO), one of the world’s largest health care suppliers, slid with the broader market on Aug. 15 after the company......
(read more)
August 27 - News - Comments
Now, according to many of your fellow readers, hedge funds are seen as useless, old investment tools of a period lost to current times. Although there......
(read more)
August 27 - News - Comments
To the average investor, there are a multitude of gauges shareholders can use to analyze their holdings. Two of the most useful are hedge fund and insider......
(read more)
August 26 - News - Comments
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......
(read more)
August 23 - Hedge Funds - Comments
What do hedge funds think about Valeant Pharmaceuticals Intl Inc (NYSE:VRX)? At the moment, there are tons of gauges investors can use to track Mr. Market......
(read more)
August 23 - News - Comments
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......
(read more)
August 21 - Hedge Funds - Comments
Several weeks after the end of each quarter, hedge funds and other major investors are required to file 13Fs with the SEC to disclose many of their long......
(read more)
August 19 - Hedge Funds - Comments
Many market-watchers are scratching their heads about the pharmaceutical industry’s latest blockbuster deal. Although it had been expected to make......
(read more)
August 12 - News - Comments
Perrigo Company (NYSE:PRGO)’s acquisition of Elan Corporation, plc (ADR) (NYSE:ELN) for $8.6 billion has been widely criticized by many as a way for......
(read more)
August 8 - News - Comments
Recently, Elan Corporation, plc (ADR) (NYSE:ELN) ended the fight against bids from Royalty Pharma. Previously, Royalty Pharma had raised its all-cash......
(read more)
August 7 - News - Comments
2013 is turning out to be a stellar year for Mergers and Acquisitions. There have been a number of M&A deals in healthcare and technology sectors.......
(read more)
August 6 - News - Comments
The chances are good that you’re a bad investor. I’m sorry if that comes as an unpleasant surprise, but if you have any doubt about it, I......
(read more)
August 5 - News - Comments
A patented drug is a cash cow for drug manufacturers. There are two ways to have a patented cash generating drug on a pharmaceutical company’s pipeline......
(read more)
August 5 - News - Comments
When I interviewed Alkermes Plc (NASDAQ:ALKS)‘ CEO Richard Pops last year, he described the relocation of the company’s headquarters to Ireland......
(read more)
July 30 - News - Comments
After months of fighting off the advances of unwanted suitor Royalty Pharma, Irish biotech Elan Corporation, plc (ADR) (NYSE:ELN) finally got an offer......
(read more)
July 29 - News - Comments
By now you’ve probably at least heard of SAC Capital, the massive hedge fund founded and run by the eponymous Steven A. Cohen. It was indicted on......
(read more)
July 29 - News - Comments
Editor’s Note: Related tickers: Chipotle Mexican Grill, Inc. (NYSE:CMG), Herbalife Ltd. (NYSE:HLF), Hess Corp. (NYSE:HES), Citigroup Inc (NYSE:C......
(read more)
July 19 - Hedge Funds - Comments
The Food and Drug Administration is investigating two deaths that occurred after patients were injected with Eli Lilly & Co. (NYSE:LLY)‘s antipsychotic......
(read more)
June 18 - News - Comments
Recently Elan Corporation, plc (ADR) (NYSE:ELN)‘s shareholders voted against management’s proposal to invest $1 billion in Theravance Inc......
(read more)
June 18 - News - Comments
Elan Corporation, plc (ADR) (NYSE:ELN) has been in the news over the past few months because of a hotly contested battle with Royalty Pharma. The battle......
(read more)
June 18 - News - Comments
It’s understandably very tempting for people with inside information to trade biotech stocks. With the potential for overnight doubles and triples......
(read more)
June 17 - News - Comments
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......
(read more)
June 17 - News - Comments
Be it efficacy or safety, Eli Lilly & Co. (NYSE:LLY) just can’t win with its Alzheimer’s disease program . The latest drug to bite the......
(read more)
June 17 - News - Comments
Seth Klarman’s Baupost Group, led by the famed value investor and author of Margin of Safety, recently revealed its public equity portfolio in......
(read more)
May 22 - Hedge Funds - Comments
Editor’s Note: Related Tickers: Goldman Sachs Group, Inc. (NYSE:GS), Citigroup Inc. (NYSE:C), J.C. Penney Company, Inc. (NYSE:JCP), Herbalife Ltd......
(read more)
May 17 - Hedge Funds - Comments
If pharmaceutical companies can break up, why not biotech companies? Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug......
(read more)
April 26 - News - Comments
After years of being plagued by a waning stock price, FDA regulatory issues and safety concerns over its blockbuster drug, its finally good to be Elan......
(read more)
April 18 - News - Comments
Biogen Idec Inc. (NASDAQ:BIIB) is one of those rare companies in the healthcare sector whose stock has relentlessly outperformed the broader market continuously......
(read more)
April 17 - News - Comments
Editor’s Note: Related tickers: UBS AG (USA) (NYSE:UBS), Morgan Stanley (NYSE:MS), Goldman Sachs Group, Inc. (NYSE:GS), Groupon Inc (NASDAQ:GRPN......
(read more)
April 16 - Hedge Funds - Comments
Last November, I examined five experimental drugs that appeared as if they had all of the tools necessary to become life-changing blockbusters from a......
(read more)
March 28 - News - Comments
Will good news from Europe echo on this side of the Atlantic within the next few days? Biogen Idec Inc. (NASDAQ:BIIB) is certainly hoping so. The biotech......
(read more)
March 25 - News - Comments
Elan Corporation, plc (ADR) (NYSE:ELN) was in 22 hedge funds’ portfolio at the end of December. ELN shareholders have witnessed a decrease in activity......
(read more)
March 25 - News - Comments